A patenting perspective on human neutrophil elastase (HNE) inhibitors (2014-2018) and their therapeutic applications

References

• Soualmia F, El Amri C. Serine protease inhibitors to treat inflammation: a patent review (2011–2016). Expert Opin Ther Pat. 2018;28(2):93–110.
   PubMed Web of Science ®Google Scholar
• Page MJ, Di Cera E. Serine peptidases: classification, structure and function. Cell Mol Life Sci. 2008;65(7–8):1220–1236.
   PubMed Web of Science ®Google Scholar
• Di Cera E. Serine proteases. IUBMB Life. 2009;61(5):510–515.
   PubMed Web of Science ®Google Scholar
• Hedstrom L. Serine protease mechanism and specificity. Chem Rev. 2002;102:4501–4524.
   PubMed Web of Science ®Google Scholar
• Rawlings ND, Barrett AJ, Bateman A. Using the MEROPS database for proteolytic enzymes and their inhibitors and substrates. Curr Protoc Bioinformatics. 2014;12(48):1–33.
   Google Scholar
• Heutinck KM, Ten Berge IJ, Hack CE, et al. Serine proteases of the human immune system in health and disease. Mol Immunol. 2010;47(11–12):1943–1955.
   PubMed Web of Science ®Google Scholar
• Perera NC, Schilling O, Kittel H, et al. NSP4, an elastase-related protease in human neutrophils with arginine specificity. Proc Natl Acad Sci USA. 2012;109(16):6229–6234.
   PubMed Web of Science ®Google Scholar
• Almeida RP, Vanet A, Witko-Sarsat V, et al. Azurocidin, a natural antibiotic from human neutrophils: expression, antimicrobial activity, and secretion. Protein Expr Purif. 1996;7(4):355–366.
   PubMed Web of Science ®Google Scholar
• Chertov O, Ueda H, Xu LL, et al. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J Exp Med. 1997;186(5):739–747.
   PubMed Web of Science ®Google Scholar
• Reeves EP, Lu H, Jacobs HL, et al. Killing activity of neutrophil is mediated through activation of proteases by K+ flux. Nature. 2002;416(6878):291–297.
   PubMed Web of Science ®Google Scholar
• Stuart LM, Ezekowitz RA. Phagocytosis: elegant complexity. Immunity. 2005;22:539–550.
   PubMed Web of Science ®Google Scholar
• Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 2003;5(14):1317–1327.
   PubMed Web of Science ®Google Scholar
• Pham CTN. Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol. 2006;6:541–550.
   PubMed Web of Science ®Google Scholar
• Pham CTN. Neutrophil serine proteases fine-tune the inflammatory response. Int J Biochem Cell Biol. 2008;40:1317–1333.
   PubMed Web of Science ®Google Scholar
• Tsai YF, Hwang TL. Neutrophil elastase inhibitors: a patent review and potential applications for inflammatory lung disease (2010–2014). Expert Opin Ther Pat. 2015;25(10):1145–1158.
   PubMed Web of Science ®Google Scholar
• Korkmaz B, Moreau T, Gauthier F. Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions. Biochimie. 2008;90:227–242.
   PubMed Web of Science ®Google Scholar
• Zimmer M, Medcalf RL, Fink TM, et al. Three human elastase-like genes coordinately expressed in the myelomonocyte lineage are organized as a single genetic locus on 19pter. Proc Natl Acad Sci USA. 1992;89(17):8215–8219.
   PubMed Web of Science ®Google Scholar
• Horwitz M, Benson KF, Person RE, et al. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic hematopoiesis. Nat Genet. 1999;23:433–436.
   PubMed Web of Science ®Google Scholar
• Horwitz MS, Duan Z, Korkmaz B, et al. Neutrophil elastase in cyclic and severe congenital neutropenia. Blood. 2007;109(5):1817–1824.
   PubMed Web of Science ®Google Scholar
• Lungarella G, Menegazzi R, Gardi C, et al. Identification of elastase in human eosinophils: immunolocalization, isolation, and partial characterization. Arch Biochem Biophys. 1992;292(1):128–135.
   PubMed Web of Science ®Google Scholar
• Tsuji N, Moriwaki S, Suzuki Y, et al. The role of elastases secreted by fibroblasts in wrinkle formation: implication through selective inhibition of elastase activity. Photochem Photobiol. 2001;74(2):283–290.
   PubMed Web of Science ®Google Scholar
• Liou TG, Campbell EJ. Nonisotropic enzyme-inhibitor interactions: a novel non-oxidative mechanism for quantum proteolysis by human neutrophils. Biochemistry. 1995;34(49):16171–16177.
   PubMed Web of Science ®Google Scholar
• Owen CA, Campbell EJ. Neutrophil proteinases and matrix degradation. The cell biology of pericellular proteolysis. Semin Cell Biol. 1995;6:367–376.
   PubMedGoogle Scholar
• Allen DH, Tracy PB. Human coagulation factor V is activated to the functional cofactor by elastase and cathepsin G expressed at the monocyte surface. J Biol Chem. 1995;270:1408–1415.
   PubMed Web of Science ®Google Scholar
• Walker B, Lynas JF. Strategies for the inhibition of serine proteases. Cell Mol Life Sci. 2001;58:596–624.
   PubMed Web of Science ®Google Scholar
• Hartley BS, Kilby BA. The reaction of p-nitrophenyl esters with chymotrypsin and insulin. Biochem J. 1954;56:288–297.
   PubMed Web of Science ®Google Scholar
• Bobofchak KM, Pineda AO, Mathews FS, et al. Energetic and structural consequences of perturbing Gly-193 in the oxyanion hole of serine proteases. J Biol Chem. 2005;280:25644–25650.
   PubMed Web of Science ®Google Scholar
• Chua F, Laurent GJ. Neutrophil elastase: mediator of extracellular matrix destruction and accumulation. Proc Am Thorac Soc. 2006;3:424–427.
   PubMedGoogle Scholar
• Bieth JG. Elastases: catalytic and biological properties. In: Mecham R, editor. Regulationof matrix accumulation. New York: Academic Press; 1986. p. 217–230.
   Google Scholar
• Gadek JE, Fells GA, Wright DG, et al. Human neutrophil elastase functions as a type III collagen “collagenase.”. Biochem Biophys Res Commun. 1980;95:1815–1822.
   PubMed Web of Science ®Google Scholar
• Janoff A, Scherer J. Mediators of inflammation in leukocyte lysosomes: elastinolytic activity in granules of human polymorphonuclear leukocytes. J Exp Med. 1968;128:1137–1155.
   PubMed Web of Science ®Google Scholar
• Barret AJ, Salvesen G. An introduction to the proteinases. In: Barrett AJ, Salvesen G (eds). Protease inhibitors. Vol. 1. New York: Elsevier; 1986. p. 1–22.
   Google Scholar
• Havemann K, Janoff A. Neutral proteases of human polymorphonuclear leukocytes. Baltimore, (MD): Urban & Schwarzenberg; 1978.
   Google Scholar
• Abe H, Okajima K, Okabe H. Granulocyte protease and hydrogen peroxide synergistically inactivate thrombomodulin of endothelial cells in vitro. J Lab Clin Med. 1994;123:874–881.
   PubMed Web of Science ®Google Scholar
• States DJ, Fells GA, Crystal RG. Susceptibility of the HIV envelope protein to attack by neutrophil elastase. Clin Res. 1989;37:482A.
   Google Scholar
• Senior RM, Campbell EJ. Neutral proteinases from human inflammatory cells. A critical review of their role in extracellular matrix degradation. Clin Lab Med. 1983;3:645–666.
   PubMed Web of Science ®Google Scholar
• Okada Y, Watanabe S, Nakanishi I, et al. Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases. FEBS Lett. 1988;229:157–160.
   PubMed Web of Science ®Google Scholar
• Cepinskas G, Sanding M, Pr K. PAF-induced elastase-dependent neutrophil trans endothelial migration is associated with the mobilization of the elastase to the neutrophil surface and localization to the migration front. J Cell Sci. 1999;112:1937–1945.
   PubMed Web of Science ®Google Scholar
• Hermant B, Bibert S, Concord E, et al. Identification of proteases involved in the proteolysis of vascular endothelium cadherin during neutrophil transmigration. J Biol Chem. 2003;278:14002–14012.
   PubMed Web of Science ®Google Scholar
• Belaaouaj A, McCarthy R, Baumann M, et al. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat Med. 1998;4(5):615–618.
   PubMed Web of Science ®Google Scholar
• Bardoel BW, Kenny EF, Sollberger G, et al. The balancing act of neutrophils. Cell Host Microbe. 2014;15(5):526–536.
   PubMed Web of Science ®Google Scholar
• Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303:1532–1535.
   PubMed Web of Science ®Google Scholar
• Kelly E, Greene CM, McElvaney NG. Targeting neutrophil elastase in cystic fibrosis. Expert Opin Ther Targets. 2008;12(2):145–157.
   PubMed Web of Science ®Google Scholar
• Cowburn AS, Condliffe AM, Farahi N, et al. Advances in neutrophil biology: clinical implications. Chest. 2008;134(3):606–612.
   PubMed Web of Science ®Google Scholar
• Von Nussbaum F, Li VMJ. Neutrophil elastase inhibitors for the treatment of (cardio)pulmonary diseases: into clinical testing with pre-adaptive pharmacophores. Bioorg Med Chem. 2015;25:4370–4381.
   Web of Science ®Google Scholar
• Stockley RA. Neutrophils and the pathogenesis of COPD. Chest. 2002;121(5):151S–155S.
   PubMed Web of Science ®Google Scholar
• Ekeowa U, Gooptu B, Belorgey D, et al. Alpha-1-antitrypsin deficiency, chronic obstructive pulmonary disease and the serpinopathies. Clin Sci (London). 2009;116:837–850.
   PubMed Web of Science ®Google Scholar
• Silverman GA, Bird PI, Carrell W, et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem. 2001;276:33293–33296.
   PubMed Web of Science ®Google Scholar
• Brew K, Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and function diversity. Biochim Biophys Acta. 2010;1803:55–71.
   PubMed Web of Science ®Google Scholar
• Turk V, Stoka V, Turk D. Cystatins: biochemical and structural properties and medical relevance. Front Biosci. 2008;13:5406–5420.
   PubMed Web of Science ®Google Scholar
• Miravitlles M. Alpha-1-antitrypsin and other proteinase inhibitors. Curr Opin Pharmacol. 2012;12:309–314.
   PubMed Web of Science ®Google Scholar
• Cooley J, Takayama TK, Shapiro SD, et al. The serpin MNEI inhibits elastase-like and chymotrypsin-like serine protease through efficient reactions at two active sites. Biochemistry. 2001;40:15762–15770.
   PubMed Web of Science ®Google Scholar
• Sallenave JM. The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease. Respir Res. 2000;1:87–92.
   PubMedGoogle Scholar
• Alam SR, Newby DE, Henriksen PA. Role of the endogenous inhibitor, elafin, in cardiovascular injury from epithelium to endothelium. Biochem Pharmacol. 2012;83:695–704.
   PubMed Web of Science ®Google Scholar
• Sun Z, Yang P. Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression. Lancet Oncol. 2004;5(3):182–190.
   PubMed Web of Science ®Google Scholar
• Rubio F, Accurso FJ, Remold-O’Donnell E. Linkage of neutrophil serine proteases and decreased surfactant protein-A (SP-A) levels in inflammatory lung disease. Thorax. 2004;59:318–323.
   PubMed Web of Science ®Google Scholar
• Boudier C, Bieth J. Mucous proteinase inhibitor: a fast acting inhibitor of leukocyte elastase. Biochem Biophys Acta. 1989;995:36–41.
   PubMed Web of Science ®Google Scholar
• Gadek JE, Pacht ER. The protease-antiprotease balance within the human lung: implications for the pathogenesis of emphysema. Lung. 1990;168(Suppl):552–564.
   PubMedGoogle Scholar
• Groutas WC, Dou D, Alliston KR. Neutrophil elastase inhibitors. Expert Opin Ther Pat. 2011;21(3):339–354.
   PubMed Web of Science ®Google Scholar
• Polverino E, Rosales-Mayor E, Dale GE, et al. The role of neutrophil elastase inhibitors in lung diseases. Chest. 2017;152(2):249–262.
   PubMed Web of Science ®Google Scholar
• Lucas SD, Costa E, Guedes RC, et al. Targeting COPD: advances on low molecular-weight inhibitors of human neutrophil elastase. Med Res Rev. 2011;33:73–101.
   Web of Science ®Google Scholar
• Barnes PJ, Stockley RA. COPD: current therapeutic interventions and future approaches. Eur Respir J. 2005;25:1084–1106.
   PubMed Web of Science ®Google Scholar
• Pandey KC, De S, Mishra PK. Role of proteases in chronic obstructive pulmonary disease. Front Pharmacol. 2017;8:512.
   PubMed Web of Science ®Google Scholar
• Ohbayashi H. Neutrophil elastase inhibitors as treatment for COPD. Expert Opin Investig Drugs. 2002;11:965–980.
   PubMed Web of Science ®Google Scholar
• Chan SCH, Shum DKY, Ip MSM. Sputum sol neutrophil elastase activity in bronchiectasis: differential modulation by syndecan-1. Am J Respir Crit Care Med. 2003;168(2):192–198.
   PubMed Web of Science ®Google Scholar
• Gramegna A, Amati F, Terranova L, et al. Neutrophil elastase in bronchiectasis. Respir Res. 2017;18:211–224.
   PubMed Web of Science ®Google Scholar
• Voynow JA, Fischer BM, Zheng S. Proteases and cystic fibrosis. Int J Biochem Cell B. 2008;40:1238–1245.
   PubMed Web of Science ®Google Scholar
• Kawabata K, Hagio T, Matsuoka S. The role of neutrophil elastase in acute lung injury. Eur J Pharmacol. 2002;451:1–10.
   PubMed Web of Science ®Google Scholar
• Wang Z, Chen F, Zhai R, et al. Plasma neutrophil elastase and elafin imbalance is associated with acute respiratory distress syndrome (ARDS) development. PLoS ONE. 2009;4:1–10.
   Web of Science ®Google Scholar
• Rabinovitch M, Guignabert C, Humbert M, et al. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res. 2014;115(1):165–175.
   PubMed Web of Science ®Google Scholar
• Schaaf B, Wieghorst A, Aries SP, et al. Neutrophil inflammation and activation in bronchiectasis: comparison with pneumonia and idiopathic pulmonary fibrosis. Respiration. 2000;67(1):52–59.
   PubMed Web of Science ®Google Scholar
• Fischer BM, Voynow JA. Neutrophil elastase induces MUC5AC gene expression in airway epithelium via a pathway involving reactive oxygen species. Am J Respir Cell Mol Biol. 2002;26:447–452.
   PubMed Web of Science ®Google Scholar
• Shao MX, Ueki IF, Nadel JA. Tumor necrosis factor α-converting enzyme mediates MUC5AC mucin expression in cultured human airway epithelial cells. Proc Natl Acad Sci USA. 2003;100:11618–11623.
   PubMed Web of Science ®Google Scholar
• Meyer-Hoffert U, Wingertszahn J, Wiedow O. Human leukocyte elastase induces keratinocyte proliferation by epidermal growth factor receptor activation. J Investig Dermatol. 2004;123:338–345.
   PubMed Web of Science ®Google Scholar
• Glinski W, Jarzabek-Chorzelska M, Kuligowski M, et al. Basement membrane zone as a target for human neutrophil elastase in psoriasis. Arch Dermatol Res. 1990;282:506–511.
   PubMed Web of Science ®Google Scholar
• Marto J, Ruivo E, Lucas SD, et al. Starch nanocapsules containing a novel neutrophil elastase inhibitor with improved pharmaceutical performance. Eur J Pharm Biopharm. 2018;127:1–11.
   PubMed Web of Science ®Google Scholar
• Marto J, Gouveia LF, Gonçalves LM, et al. A quality by design (QbD) approach on starch-based nanocapsules: a promising platform for topical drug delivery. Colloids Surf B Biointerfaces. 2016;143:177–185.
   PubMed Web of Science ®Google Scholar
• Areias L, Ruivo E, Gonçalves L, et al. A unified approach toward the rational design of selective low nanomolar human neutrophil elastase inhibitors. RSC Adv. 2015;5(64):51717–51721.
   Web of Science ®Google Scholar
• Cawston TE, Young DA. Proteinases involved in matrix turnover during cartilage and bone breakdown. Cell Tissue Res. 2010;339:221–235.
   PubMed Web of Science ®Google Scholar
• Di Cesare Mannelli L, Micheli L, Cinci L, et al. Effects of the neutrophil elastase inhibitor EL-17 in rat adjuvant-induced arthritis. Rheumatology. 2016;55:1285–1294.
   PubMed Web of Science ®Google Scholar
• Crocetti L, Schepetkin IA, Cilibrizzi A, et al. Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase. J Med Chem. 2013;56:6259–6272.
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–867.
   PubMed Web of Science ®Google Scholar
• Demaria S, Pikarsky E, Karin M, et al. Cancer and inflammation: promise for biologic therapy. J Immunother. 2010;33:335–351.
   PubMed Web of Science ®Google Scholar
• Sato T, Takahashi S, Mizumoto T, et al. Neutrophil elastase and cancer. J Surg Oncol. 2006;15:217–222.
   Google Scholar
• Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol. 2012;196:395–406.
   PubMed Web of Science ®Google Scholar
• Yamashita J, Tashiro K, Yoneda S, et al. Local increase in polymorphonuclear leukocyte elastase is associated with tumor invasiveness in non-small cell lung cancer. Chest. 1996;109:1328–1334.
   PubMed Web of Science ®Google Scholar
• Akizuki M, Fukutomi T, Takasugi M, et al. Prognostic significance of immunoreactive neutrophil elastase in human breast cancer: long-term follow-up results in 313 patients. Neoplasia. 2007;9(3):260–264.
   PubMed Web of Science ®Google Scholar
• Vaguliene N, Zemaitis M, Lavinskiene S, et al. Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease. BMC Immunol. 2013;14:36.
   PubMed Web of Science ®Google Scholar
• Antonicelli F, Bellon G, Debelle L, et al. Elastin-elastases and inflamm-aging. Curr Top Dev Biol. 2007;79:99–155.
   PubMed Web of Science ®Google Scholar
• Coffelt SB, Wellenstein MD, de Visser KE. Neutrophils in cancer: neutral no more. Nat Rev Cancer. 2016;16(7):431–446.
   PubMed Web of Science ®Google Scholar
• Marvel D, Gabrilovich DI. Myeloid-derived suppressor cells in the tumor micro-environment: expect the unexpected. J Clin Invest. 2016;125(9):3356–3364.
   Web of Science ®Google Scholar
• Lerman I, Hammes SR. Neutrophil elastase in the tumor microenvironment. Steroids. 2017;133:96–101.
   PubMed Web of Science ®Google Scholar
• Lerman I, Garcia-Hernandez ML, Rangel-Moreno J, et al. Infiltrating myeloid cells exert pro-tumorigenic actions via neutrophil elastase. Mol Cancer Res. 2017;15(9):1138–1152.
   PubMed Web of Science ®Google Scholar
• Wang Y, Xiao Y, Zhong L, et al. Increased neutrophil elastase and proteinase 3 and augmented NETosis are closely associated with beta-cell autoimmunity in patients with type I diabetes. Diabetes. 2014;63(12):4239–4248.
   PubMed Web of Science ®Google Scholar
• Vicuña L, Simonetti M, Bali KK, et al. Selective inhibitors of neutrophil elastase for treating neuropathic pain and chronic pain states harbouring a neuropathic component. WO 2016050835 A2. 2016.
   Google Scholar
• Vicuña L, Strochlic DE, Latremoliere A, et al. The serine protease inhibitor SerpinA3N attenuates neuropathic pain by inhibiting T cell-derived leukocyte elastase. Nat Med. 2015;21(5):518–523.
   PubMed Web of Science ®Google Scholar
• Weyer AD, Stucky CL. Repurposing a leukocyte elastase inhibitor for neuropathic pain. Nat Med. 2015;21(5):429–430.
   PubMed Web of Science ®Google Scholar
• Balia KK, Kuner R. Therapeutic potential for leukocyte elastase in chronic pain states harboring a neuropathic component. Pain. 2017;158(11):2243–2258.
   PubMed Web of Science ®Google Scholar
• Bronze-da-Rocha E, Santos-Silva A. Neutrophil elastase inhibitors and chronic kidney disease. Int J Biol Sci. 2018;14(10):1343–1360.
   PubMed Web of Science ®Google Scholar
• Pereira R, Rocha S, Borges A, et al. Elastase release during the hemodialysis procedure seems to induce changes in red blood cell membrane proteins. Hemodial Int Int Symp Home Hemodial. 2011;15:429–431.
   PubMed Web of Science ®Google Scholar
• Polanska B, Augustyniak D, Makulska I, et al. Elastase, alpha1-proteinase inhibitor, and interleukin-8 in children and young adults with end-stage kidney disease undergoing continuous ambulatory peritoneal dialysis. Arch Immunol Ther Ex. 2014;62:239–245.
   PubMed Web of Science ®Google Scholar
• Langhorst J, Elsenbruch S, Koelzer J, et al. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol. 2008;103:162–169.
   PubMed Web of Science ®Google Scholar
• Wen G, An W, Chen J, et al. Genetic and pharmacologic inhibition of the neutrophil elastase inhibits experimental atherosclerosis. J Am Heart Assoc. 2018;7(4):e008187.
   PubMed Web of Science ®Google Scholar
• Matsuse H, Yanagihara K, Mukae H, et al. Association of plasma neutrophil elastase levels with other inflammatory mediators and clinical features in adult patients with moderate and severe pneumonia. Respir Med. 2007;101(7):1521–1528.
   PubMed Web of Science ®Google Scholar
• Arafat SN, Robert MC, Abud T, et al. Elevated neutrophil elastase in tears of ocular graft-versus-host disease patients. Am J Ophthalmol. 2017;176:46–52.
   PubMed Web of Science ®Google Scholar
• Bayer Corp: Prolastin. 2002. Company World Wide Web Site. Available from: http://edoc.com/prolastin
   Google Scholar
• Iwata K, Doi A, Ohji G, et al. Effect of neutrophil elastase inhibitor (sivelestat sodium) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): a systematic review and meta-analysis. Intern Med. 2010;49:2423–2432.
   PubMed Web of Science ®Google Scholar
• Aikawa N, Kawasaki Y. Clinical utility of the neutrophil elastase inhibitor sivelestat for the treatment of acute respiratory distress syndrome. Ther Clin Risk Manage. 2014;10:621–629.
   PubMed Web of Science ®Google Scholar
• Bernstein PR, Edwards PD, Williams JC. 2 Inhibitors of human leukocyte elastase. In: Ellis GP, Luscombe DK, editors. Progress in medicinal chemistry. Vol. 31. Amsterdam: Elsevier; 1994. p. 59–120.
   Google Scholar
• Siedle B, Hrenn A, Merfort I. Natural compounds as inhibitors of human neutrophil elastase. Planta Med. 2007;73(5):401–420.
   PubMed Web of Science ®Google Scholar
• Martins FT, Assis DM, Dos Santos MH, et al. Natural polyprenylated benzophenones inhibiting cysteine and serine protease. Eur J Med Chem. 2009;44:1230–1239.
   PubMed Web of Science ®Google Scholar
• Kim JY, Wang Y, Uddin Z, et al. Competitive neutrophil elastase inhibitory isoflavones from the roots of flemingia Philippinensis. Bioorg Chem. 2018;78:249–257.
   PubMed Web of Science ®Google Scholar
• Uddin Z, Zuopeng L, Song YH, et al. Visconata: A rare flavonol having long chain fatty acid from Dodonaea viscosa which inhibits Human neutrophil elastase (HNE). Tetrahedron Lett. 2017;58(21):2507–2511.
   Google Scholar
• Salvador LA, Taori K, Biggs JS, et al. Potent elastase inhibitors from cyanobacteria: structural basis and mechanisms mediating cytoprotective and anti-inflammatory effects in bronchial epithelial cells. J Med Chem. 2013;56:1276–1290.
   PubMed Web of Science ®Google Scholar
• Luo D, Chen Q-Y, Luesch H. Total synthesis of the potent marine-derived elastase inhibitor lyngbyastatin 7 and in vitro biological evaluation in model systems for pulmonary diseases. J Org Chem. 2016;81:532–544.
   PubMed Web of Science ®Google Scholar
• Sorroche PB, Fernández Acquier M, López Jove O, et al. Alpha-1 antitrypsin deficiency in COPD patients: a cross-sectional study. Arch Bronconeumol. 2015;51(11):539–543.
   PubMed Web of Science ®Google Scholar
• Clinicaltrials.gov NCT study code NCT02722304. 2018.
   Google Scholar
• Abouzaki NA, Christopher S, Trankle C, et al. Inhibiting the inflammatory injury after myocardial ischemia reperfusion with plasma-derived alpha-1 antitrypsin: a post Hoc analysis of the VCU-α1RT Study. J Cardiovasc Pharmacol. 2018;71(6):375–379.
   PubMed Web of Science ®Google Scholar
• Clinicaltrials.gov. NCT study code NCT01936896. 2016.
   Google Scholar
• Magenau JM, Goldstein SC, Peltier D, et al. α1-antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease. Blood. 2018;131(12):1372–1379.
   PubMed Web of Science ®Google Scholar
• Clinicaltrials.gov. NCT study code NCT01700036. 2018.
   Google Scholar
• Marcondes AM, Karoopongse E, Lesnikova M, et al. α-1-antitrypsin (AAT)–modified donor cells suppress GVHD but enhance the GVL effect: a role for mitochondrial bioenergetics. Blood. 2014;124(18):2881–2891.
   PubMed Web of Science ®Google Scholar
• Clinicaltrials.gov. NCT study code NCT01523821. 2018.
   Google Scholar
• Chun HJ, Yu PB. Elafin in pulmonary arterial hypertension. Beyond targeting elastases. Am J Respir Crit Care Med. 2015;191(11):1217–1219.
   PubMed Web of Science ®Google Scholar
• Clinicaltrials.gov. NCT study code NCT03522935. 2019.
   Google Scholar
• Luther A, Moehle K, Chevalier E, et al. Protein epitope mimetic macrocycles as biopharmaceuticals. Curr Opin Chem Biol. 2017;38:45–51.
   PubMed Web of Science ®Google Scholar
• Clinicaltrials.gov. NCT study core NCT03748199. 2018.
   Google Scholar
• Obrecht D, Chevalier E, Moehle K, et al. β-hairpin protein mimetic technology in drug discovery. Drug Discov Today. 2012;9:e63–e69.
   Google Scholar
• Gombert FO, Obrecht D, Sellier-Kessler O, et al. Beta-hairpin peptidomimetics as selective elastase inhibitors. WO 2015/096873 A1. 2015.
   Google Scholar
• Ludin C, Keller M Beta-hairpin peptidomimetic with elastase inhibitory acivity and aereosol dosage forms thereof. WO 2017/207117 A1. 2017.
   Google Scholar
• Clinicaltrials.gov. NCT study code NCT03636347. 2019.
   Google Scholar
• Clinicaltrials.gov. NCT study code NCT03679598. 2019.
   Google Scholar
• Clinicaltrials.gov. NCT study code NCT02669251. 2018.
   Google Scholar
• Von Nussbaum F, Li VM-J, Allerheiligen S, et al. Freezing the bioactive conformation to boost potency: the identification of BAY 85-8501, a selective and potent inhibitor of human neutrophil elastase for pulmonary diseases. ChemMedChem. 2015;10:1163–1173.
   PubMed Web of Science ®Google Scholar
• Clinicaltrials.gov. NCT study core NCT01818544. 2015.
   Google Scholar
• Carnini C, Brogin G, Patacchini R, et al. CHF6333: pharmacological and pharmacokinetic characterization of a novel potent inhaled inhibitor of neutrophil elastase. Am J Respir Crit Care Med. 2017;195:A4420.
   Web of Science ®Google Scholar
• Clinicaltrials.gov. NCT study core NCT03056326. 2017.
   Google Scholar
• Miglietta D, Carnini C, Puviani V, et al. Pharmacological characterization of CHF6333, a novel potent inhaled inhibitor of neutrophil elastase. ERS International Congress, London. 2016.
   Google Scholar
• Alcaraz L, Heald RA, Sutton JM, et al. Pyrimidone compounds which are HNE inhibitors. US 9868740 B2 2018.
   Google Scholar
• Alcaraz L, Heald RA, Sutton JM, et al. 3-Oxo-2,3,5,8-tetrahydro-[1,2,4]triazolo[4,3-A]pyrimidine derivatives for the treatment of respiratory diseases. EP 2935274 B1. 2018.
   Google Scholar
• Armani E, Capaldi C, Sutton JM, et al. Compounds. US 9487528 B2. 2016.
   Google Scholar
• Armani E, Capaldi C Triazolinone compounds as HNE inhibitors. US 9890169 B2. 2018.
   Google Scholar
• Edwards C, Kulagowski J, Finch H Pyrimidine derivatives and their use in the treatment of respiratory diseases such as COPD. EP 2545057 B1. 2017.
   Google Scholar
• Capaldi C, Heald RA, Ray NC, et al. Inhibition of enzymes. US 9199984 B2. 2015
   Google Scholar
• Armani E, Capaldi C, Sutton JM, et al. Compounds. US 9409870 B2. 2016.
   Google Scholar
• Capaldi C, Armani E, Jennings ASR Compounds. US 9862706 B2. 2018.
   Google Scholar
• Sutton JM, Heald RA, Jennings ASR, et al. Novel compounds. US 2017/0340611. 2017.
   Google Scholar
• Oost T, Fiegen D, Substituted GC 4-pyridones and their use as inhibitors of neutrophil elastase activity. EP 2888242 B1. 2016.
   Google Scholar
• Oost T, Fiegen D, Gnamm C, et al. Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity. EP 2888248 B1. 2016.
   Google Scholar
• Oost T, Fiegen D, Gnamm C, et al. Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity. EP 2888249 B1. 2016.
   Google Scholar
• Gnamm C, Oost T Substituted pyridones and pyrazinones and their use as inhibitors of neutrophil elastase activity. EP 3107911 B1. 2018.
   Google Scholar
• Peters S, Anderskewitz R, Morschhaeuser G, et al. Substituted dihydropyrimidones and their use as inhibitors of neutrophil elastase activity. EP 3174860 B1. 2018.
   Google Scholar
• Oost T, Anderskewitz R, Gnamm C, et al. Substituted bicyclic dihydropyrimidones and their use as inhibitors of neutrophil elastase activity. US 9475779 B2. 2016.
   Google Scholar
• Peters S, Anderskewitz R, Gnamm C, et al. Substituted bicyclic dihydropyrimidones and their use as inhibitors of neutrophil elastase activity. US 9458113 B2. 2016.
   Google Scholar
• Gnamm C, Oost T, Peters S, et al. Substituted bicyclic dihydropyrimidones and their use as inhibitors of neutrophil elastase activity. US 9670166 B2. 2017.
   Google Scholar
• Gnamm C, Oost T, Peters S, et al. Substituted bicyclic dihydropyrimidones and their use as inhibitors of neutrophil elastase activity. US 9115093 B2. 2015.
   Google Scholar
• Oost T, Anderskewitz R, Gnamm C, et al. Substituted bicyclic dihydropyrimidones and their use as inhibitors of neutrophil elastase activity. US 9440930 B2. 2016.
   Google Scholar
• Gnamm C, Anderskewitz R, Hoesch H, et al. Substituted bicyclic dihydropyrimidones and their use as inhibitors of neutrophil elastase activity. US 9657015 B2. 2017.
   Google Scholar
• Von Nussbaum F, Karthaus D, Anlauf S, et al. 4-(4-cyano-2-thioaryl)dihydro-pyrimidones and use thereof. US 2015/0045344 A1. 2015.
   Google Scholar
• Von Nussbaum F, Karthaus D, Anlauf S, et al. Triazolo and tetrazolo pyrimidine derivatives as HNE inhibitors for treating COPD. US 9359362 B2. 2016.
   Google Scholar
• Von Nussbaum F, Li VM, Meibom D, et al. Potent and selective human neutrophil elastase inhibitors with novel equatorial ring topology: in vivo efficacy of the polar pyrimidopyridazine BAY-8040 in a pulmonary arterial hypertension rat model. Chem Med Chem. 2016;11:199–206.
   Google Scholar
• Hansen P, Ivarsoon M, Lawitz K, et al. 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. CA 2650553 C. 2014.
   Google Scholar
• Yamada K, Yanagihara K, Araki N, et al. In vivo efficacy of KRP-109, a novel elastase inhibitor, in a murine model of severe pneumococcal pneumonia. Pulm Pharmacol Ther. 2011;24:660–665.
   PubMed Web of Science ®Google Scholar
• Chillappagari S, Müller C, Mahavadi P, et al. A small molecule neutrophil elastase inhibitor, KRP-109, inhibits cystic fibrosis mucin degradation. J Cyst Fibros. 2016;15:325–331.
   PubMed Web of Science ®Google Scholar
• Chatterjee AK, Kumar M, Schultz PG Elastase inhibitors. US 2017/0144998 A1. 2017.
   Google Scholar
• Vergelli C, Schepetkin IA, Crocetti L, et al. Isoxazol5(2H)-one: a new scaffold for potent human neutrophil elastase (HNE) inhibitors. J Enz Inhib Med Chem. 2017;32(1):821–831.
   PubMed Web of Science ®Google Scholar
• Giovannoni MP, Schepetkin IA, Quinn MT, et al. Synthesis, biological evaluation, and molecular modelling studies of potent human neutrophil elastase (HNE) inhibitors. J Enz Inhib Med Chem. 2018;33(1):1108–1124.
   PubMed Web of Science ®Google Scholar
• Crocetti L, Giovannoni MP, Schepetkin IA, et al. Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase. Bioorg Med Chem. 2011;19:4460–4472.
   PubMed Web of Science ®Google Scholar
• Crocetti L, Schepetkin IA, Ciciani G, et al. Synthesis and pharmacological evaluation of indole derivatives as deaza analogues of potent human neutrophil elastase inhibitors. Drug Dev Res. 2016;77:285–299.
   PubMed Web of Science ®Google Scholar
• Giovannoni MP, Schepetkin IA, Crocetti L, et al. Cinnoline derivatives as human neutrophil elastase inhibitors. J Enz Inhib Med Chem. 2016;31(4):628–639.
   PubMed Web of Science ®Google Scholar
• Crocetti L, Bartolucci G, Cilibrizzi A, et al. Synthesis and analytical characterization of new thiazol-2- (3H)- ones as human neutrophil elastase (HNE) inhibitors. Chem Cent J. 2017;11:127–142.
   PubMedGoogle Scholar
• Crocetti L, Giovannoni MP, Schepetkin IA, et al. 1H-pyrrolo[2,3-b]pyridine: a new scaffold for human neutrophil elastase (HNE) inhibitors. Bioorg Med Chem. 2018;26:5583–5595.
   PubMed Web of Science ®Google Scholar
• António JPM, GonçAlves LM, Guedes RC, et al. Diazaborines as new inhibitors of human neutrophil elastase. ACS Omega. 2018;3:7418–7423.
   PubMed Web of Science ®Google Scholar
• Heisch P-W, Hwang T-L, Wang W-H, et al. Oxime-based compound, pharmaceutical composition containing the same and method for preparing the same. US 9073833 B1. 2015.
   Google Scholar
• Hwang T-L, Wang W-H, Wang T-Y, et al. Synthesis and pharmacological characterization of 2-aminobenzaldeyde oxime analogs as dual inhibitors of neutrophil elastase and proteinase 3. Bioorg Med Chem. 2015;23:1123–1134.
   PubMed Web of Science ®Google Scholar
• Xu A, Wang Y, Zhong L, et al. Methods and compositions for use of neutrophil elastase and proteinase 3 as diagnostic biomarkers. US 9625460 B2. 2017.
   Google Scholar
• Doyle K, Lönn H, Käck H, et al. Discovery of second generation reversible covalent DPP1 inhibitors leading to an oxazepane amidoacetonitrile based clinical candidate (AZD7986). J Med Chem. 2016;59:9457–9472.
   PubMed Web of Science ®Google Scholar